Trial Watch: Toll-like receptor agonists in oncological indications.

Details
Category: Impact Factor 5

Oncoimmunology

1 août 2014
Trial Watch: Toll-like receptor agonists in oncological indications.

Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Henrik Ter Meulen J, Zitvogel L, Kroemer G, Galluzzi L.